ES2077417T3 - Composiciones farmaceuticas ingeribles para tratar malestares del tracto gastrointestinal superior. - Google Patents

Composiciones farmaceuticas ingeribles para tratar malestares del tracto gastrointestinal superior.

Info

Publication number
ES2077417T3
ES2077417T3 ES92910661T ES92910661T ES2077417T3 ES 2077417 T3 ES2077417 T3 ES 2077417T3 ES 92910661 T ES92910661 T ES 92910661T ES 92910661 T ES92910661 T ES 92910661T ES 2077417 T3 ES2077417 T3 ES 2077417T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compositions
gastrointestinal tract
upper gastrointestinal
ingerible
discomforts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92910661T
Other languages
English (en)
Inventor
James Grigg Upson
Carmelita Macklin Russell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Application granted granted Critical
Publication of ES2077417T3 publication Critical patent/ES2077417T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

COMPOSICIONES FARMACEUTICAS QUE SE PUEDEN INGERIR, COMPRENDIENDO ELEMENTOS ACTIVOS FARMACEUTICOS UTILES PARA EL TRATAMIENTO DE ANOMALIAS DEL TRACTO SUPERIOR GASTROINTESTINAL (POR EJEMPLO, AGENTES ANTIACIDOS) Y 3 EN CANTIDADES EFICACES PARA PROPORCIONAR UNA SENSACION DE ENFRIAMIENTO A LA GARGANTA.
ES92910661T 1991-04-04 1992-03-13 Composiciones farmaceuticas ingeribles para tratar malestares del tracto gastrointestinal superior. Expired - Lifetime ES2077417T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US68045991A 1991-04-04 1991-04-04

Publications (1)

Publication Number Publication Date
ES2077417T3 true ES2077417T3 (es) 1995-11-16

Family

ID=24731206

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92910661T Expired - Lifetime ES2077417T3 (es) 1991-04-04 1992-03-13 Composiciones farmaceuticas ingeribles para tratar malestares del tracto gastrointestinal superior.

Country Status (16)

Country Link
EP (1) EP0578768B1 (es)
JP (1) JPH06506682A (es)
KR (1) KR100238565B1 (es)
AT (1) ATE128351T1 (es)
AU (1) AU665349B2 (es)
BR (1) BR9205827A (es)
CA (1) CA2106215C (es)
CZ (1) CZ282105B6 (es)
DE (1) DE69205158T2 (es)
DK (1) DK0578768T3 (es)
ES (1) ES2077417T3 (es)
GR (1) GR3017580T3 (es)
HU (1) HU213203B (es)
RU (1) RU2126249C1 (es)
SK (1) SK121293A3 (es)
WO (1) WO1992017164A1 (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08502288A (ja) * 1992-10-09 1996-03-12 ザ、プロクター、エンド、ギャンブル、カンパニー 感昌症状を治療するための医薬組成物及び用法
GB9221414D0 (en) * 1992-10-13 1992-11-25 Glaxo Group Ltd Pharmaceutical compositions
WO1994025009A1 (en) * 1993-04-30 1994-11-10 The Procter & Gamble Company Coated pharmaceutical compositions
PT698393E (pt) * 1993-05-19 2002-10-31 Hisamitsu Pharmaceutical Co Agente de solubilizacao e preparacao para uso externo contendo o mesmo
AU7565594A (en) * 1993-08-17 1995-03-14 Applied Analytical Industries, Inc. Oral compositions of h2-antagonists
US5451401A (en) * 1993-09-29 1995-09-19 The Procter & Gamble Company Diphosphonic acid esters as tartar control agents
US5762962A (en) * 1994-10-05 1998-06-09 Warner-Lambert Company Antacid pharmaceutical composition
EP0725630A1 (en) * 1993-10-28 1996-08-14 The Procter & Gamble Company Fast dissolving dosage forms containing magnesium aluminum silicate and multiple active ingredients
US5399356A (en) * 1994-03-24 1995-03-21 The Procter & Gamble Company Process for making solid dose forms containing bismuth
WO1995025521A1 (en) * 1994-03-24 1995-09-28 The Procter & Gamble Company Solid dose forms containing bismuth
CO4410201A1 (es) * 1994-07-20 1997-01-09 Colgate Palmolive Co Metodos y composiciones farmaceuticas para el tratamiento de transtornos gastricos
US5713131A (en) * 1995-06-30 1998-02-03 The Gillette Company Shaving aid composite with a non-volatile cooling agent
DE19529862A1 (de) * 1995-08-14 1997-02-20 Rhone Poulenc Rorer Gmbh Pharmazeutische, oral anwendbare Zubereitung
IL230419A0 (en) * 2013-05-23 2014-04-30 Naveh Pharma 1996 Ltd Products containing magnesium and their uses

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1353381A (en) * 1971-02-04 1974-05-15 Wilkinson Sword Ltd Substituted p-menthanes and compositions containing them
US4060091A (en) * 1972-01-28 1977-11-29 Wilkinson Sword Limited Tobacco and tobacco-containing manufactures containing an ingredient having physiological cooling activity
JPS5888334A (ja) * 1981-11-20 1983-05-26 Takasago Corp ３−ｌ−メントキシプロパン−１、２−ジオ−ル

Also Published As

Publication number Publication date
GR3017580T3 (en) 1995-12-31
RU2126249C1 (ru) 1999-02-20
DK0578768T3 (da) 1996-02-05
AU1761492A (en) 1992-11-02
HUT65881A (en) 1994-07-28
DE69205158D1 (de) 1995-11-02
HU9302970D0 (en) 1994-01-28
JPH06506682A (ja) 1994-07-28
CA2106215C (en) 1997-05-27
CA2106215A1 (en) 1992-10-05
WO1992017164A1 (en) 1992-10-15
EP0578768B1 (en) 1995-09-27
HU213203B (en) 1997-03-28
CZ282105B6 (cs) 1997-05-14
DE69205158T2 (de) 1996-04-18
AU665349B2 (en) 1996-01-04
ATE128351T1 (de) 1995-10-15
SK121293A3 (en) 1994-07-06
EP0578768A1 (en) 1994-01-19
CZ226093A3 (en) 1994-04-13
BR9205827A (pt) 1994-06-28
KR100238565B1 (ko) 2000-02-01

Similar Documents

Publication Publication Date Title
ES2077417T3 (es) Composiciones farmaceuticas ingeribles para tratar malestares del tracto gastrointestinal superior.
DK0396404T3 (da) Farmaceutisk middel indeholdende loratadin, ibuprofen og pseudoephedrin
DE69213010D1 (de) Verwendung eines Bakteriozin antibiotischen Agenten zur Herstellung eines Arzneimittels zur Behandlung von Magenverstimmungen, die durch Helicobacter pylori verursacht werden.
DE60126923D1 (de) Therapeutische zusammensetzungen bestehend aus antihypotensiva und antiangiogenika
ATE113834T1 (de) Zusammensetzung zur behandlung der schizophrenie.
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
KR950002785A (ko) 골량을 증가시키기 위한 부갑상선 호르몬 및 랄옥시펜
NO902280L (no) Ny poroes farmasoeytisk form og fremstilling derav.
EE05311B1 (et) Meetod mineraalse t„iteaine t””tlemiseks poldialklsiloksaani ja rasvhappega, saades hdrofoobsed t„iteained, ja nende kasutamine polmeerides ''hingavate'' kilede jaoks
AR020662A1 (es) Compuestos dihidrotiazoles policiclicos, procedimientos para su preparacion, medicamento, procedimiento para la preparacion de dicho medicamento y lautilizacion de dichos compuestos para la preparacion de un medicamento.
BR9508373A (pt) Preparação farmacêutica uso da preparação farmacêutica e processos para preparar a preparação farmacêutica e para aliviar dor
DK0470117T3 (da) Anvendelse af "calcitonin gene-related peptides" til fremstilling af lægemidler til behandling af erektile dysfunktioner
ATA186692A (de) Pharmazeutische zusammensetzung
GT199100051A (es) Composiciones farmaceuticas y metodos para aliviar sintomas de dolores gastrointestinales inducidos por drogas antiinflamatorias no esteroidales
KR890003390A (ko) 골다공증 및 관련된 장해의 치료방법
KR910700059A (ko) 위장관의 장해 약제치료용 디메틸폴리실옥산사용
KR950013513A (ko) 약제 제조용 모에노마이신 및 이의 유도체, 및 모에노마이신 또는 이의 유도체를 함유하는 약제
BR0206087A (pt) Formulação de enxaguamento redutora para uso com ozÈnio no tratamento de cáries dentárias
DE69132392T2 (de) Pharmazeutische zusammensetzungen von gallium-komplexen von 3-hydroxy-4-pyronen
ES2094093B1 (es) Formulaciones farmaceuticas liquidas microbiologicamente estables para un carbonato basico de aluminio y magnesio.
Fenech Brucellosis in the Mediterranean: Stamps Commemorate Progress and a New Vaccine.
UA31739A (uk) Спосіб лікування деструктивних процесів шлункa та дванадцятипалої кишки
ITMI20010971A0 (it) Formulazioni farmaceutiche e/o dietetiche contenenti colostro e uso del colostro per il trattamento dell'acne
TH13515EX (th) สารที่ใช้เป็นยาสำหรับรักษาอาการอักเสบหรือบรรเทาอาการปวด
RU2000119211A (ru) Препарат для лечения и профилактики эндометритов у коров и свиноматок "метраген"

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 578768

Country of ref document: ES